Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Document › Details

Immunicum AB. (10/16/18). "Press Release: Immunicum AB (publ) Clarifies Information Regarding Directed Issue [Not for US, AU, CA, et al.]".

Organisations Organisation Immunicum AB (publ) (Nasdaq Stockholm: IMMU.ST)
  Group Immunicum (Group)
  Organisation 2 Sweden (govt)
Products Product ilixadencel
  Product 2 investment banking
Index term Index term Immunicum–SEVERAL: investment, 201810– capital increase SEK351m with 40.3m new shares at SEK8.5/share
Persons Person de Sousa, Carlos (Immunicum 201610– CEO before Zealand Pharma + Nycomed/Takeda + Pfizer + Novartis + BBB Therapeutics)
  Person 2 Gertz, Michaela (Immunicum 201802– CFO before PledPharma AB + Accelerator Nordic AB + ITP Invest AB)

Record changed: 2018-10-20


Picture [iito] Plain Stupid Simple 650x80px

More documents for Immunicum (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top